Dec 12, 2016 13:03 pm UTC| Business
VANCOUVER, British Columbia, Dec. 12, 2016 -- Cuba Ventures Corp. (TSX-V:CUV) (OTCBB:MPSFF) (the “Company”) is pleased to announce that the Company has engaged Think Tank Labs to overhaul 166 of the company’s websites...
New Low-Power PIC24 “GA7” Microcontroller Family Now Available
Dec 12, 2016 13:02 pm UTC| Business
CHANDLER, Ariz., Dec. 12, 2016 -- The new PIC24 “GA7” family of microcontrollers (MCU) is now available from Microchip Technology Inc. (NASDAQ:MCHP), a leading provider of microcontroller, mixed-signal, analog and...
Bayport International Announces New Corporate Website
Dec 12, 2016 13:01 pm UTC| Business
DALLAS, Dec. 12, 2016 -- Bayport International Holdings, Inc. (OTC PINK:BAYP) announced today through its CEO, Clay Franks, the launch of a new corporate website at BayportHoldings.com. Mr. Franks stated, “This new...
Bayport International Announces New Corporate Website
Dec 12, 2016 13:01 pm UTC| Business
DALLAS, Dec. 12, 2016 -- Bayport International Holdings, Inc. (OTC PINK:BAYP) announced today through its CEO, Clay Franks, the launch of a new corporate website at BayportHoldings.com. Mr. Franks stated, “This new...
German Consumer Goods Manufacturer Selects End-to-End AP Automation Solution from Top Image Systems
Dec 12, 2016 13:01 pm UTC| Business
TEL AVIV, Israel and COLOGNE, Germany, Dec. 12, 2016 -- Top Image Systems Ltd. (NASDAQ:TISA) a global innovator of intelligent content processing solutions, announced today that a mid-sized German consumer goods...
German Consumer Goods Manufacturer Selects End-to-End AP Automation Solution from Top Image Systems
Dec 12, 2016 13:01 pm UTC| Business
TEL AVIV, Israel and COLOGNE, Germany, Dec. 12, 2016 -- Top Image Systems Ltd. (NASDAQ:TISA) a global innovator of intelligent content processing solutions, announced today that a mid-sized German consumer goods...
Dec 12, 2016 13:01 pm UTC| Business
Thought to be autoimmune in nature, the multiple sclerosis (MS) inflammatory process is also consistent with an infectious disease; The CEASE-MS Phase IIa proof-of-concept (PoC), single-arm, open-label study was designed...